Cloderm Shortage Update: What Patients Need to Know in 2026

If you've been searching for information on a Cloderm shortage, you're in the right place. Here's everything patients need to know about Cloderm (clocortolone pivalate) availability in 2026 — including why it can be surprisingly hard to fill even without a formal shortage.

Current Cloderm Shortage Status in 2026

As of 2026, the FDA does not list clocortolone pivalate (Cloderm) on its official Drug Shortage Database. This means there is no nationally declared manufacturing or supply shortage of this medication at the time of this writing. Generic versions of clocortolone pivalate are available from multiple manufacturers, including Dr. Reddy's and Prasco.

However — and this is important — not being on the FDA shortage list doesn't mean your local pharmacy has it on the shelf. This is a distinction many patients find confusing.

Why Cloderm Is Hard to Find Even Without a Shortage

There's a difference between a drug being available in the supply chain and it being stocked at your specific pharmacy. Cloderm faces several structural availability challenges:

• Niche prescribing volume. Cloderm is primarily prescribed by dermatologists, often specifically for patients with sensitive skin or histories of corticosteroid contact reactions. Most pharmacies fill far fewer clocortolone prescriptions than, say, triamcinolone — so they often don't stock it.
• High retail price. At $350–$450 retail for a tube of brand-name Cloderm, inventory turnover is slow at pharmacies that don't specialize in dermatology medications.
• Step therapy insurance barriers. Insurance-required prior authorizations and step therapy requirements mean that even if a pharmacy has it, your insurer may not cover it without additional documentation from your prescriber.
• Limited formulations. Clocortolone pivalate is only available as a cream — no ointment, gel, or solution. Combined with specific tube sizes (45g, 90g, 75g pump), not every size may be at every pharmacy.

What Does the Availability Picture Look Like?

The overall availability picture for Cloderm is generally stable, but with localized frustration. Most patients can fill their prescription — it just may require calling around or asking their pharmacy to order it. The findability challenge is structural, not a supply chain emergency.

Generic clocortolone pivalate from Dr. Reddy's and Prasco provides additional supply options, and most large pharmacy chains can order either the brand or generic within 1–2 business days if it's not on their shelves.

What Should Patients Do Right Now?

If you're having trouble filling Cloderm, here's your action plan:

1. Use medfinder to have pharmacies near you checked for clocortolone pivalate inventory without spending your time on hold.
2. Ask your current pharmacy if they can order it — most can place a special order within 1–2 business days at no extra cost to you.
3. Check if your insurance requires a prior authorization — if so, contact your prescriber's office to initiate it.
4. Ask your prescriber if the generic (clocortolone pivalate) is acceptable if brand-name Cloderm is unavailable.
5. If truly unable to fill, discuss alternative Class 4 topical steroids with your doctor — triamcinolone acetonide or mometasone furoate are commonly available alternatives.

What If My Skin Condition Flares While I Wait?

Don't let a prescription delay worsen your skin. Contact your prescriber promptly if:

• Your eczema or dermatitis is spreading significantly
• You have no remaining medication for a flare
• You develop signs of secondary infection (increased redness, warmth, pus, fever)

Your prescriber can bridge you with an appropriate alternative while your preferred medication is obtained.

The Bottom Line

There is no FDA-listed shortage of Cloderm in 2026, but finding it at your local pharmacy still takes effort. Use the strategies above, leverage tools like medfinder to find it faster, and keep your prescriber in the loop so your skin condition doesn't go untreated while you search.